Aren't executives just responding rationally to the current environment? Right or wrong, the broadly speaking, the current thinking is that GenAI will be super impactful. Which means there is a lot of risk to be seen as underinvesting in GenAI, even when the ROI isn't there. Until the hype dies down and there is a broad, practical understanding of the value of GenAI, I don't see how it could work anyother way.